Fecal short-chain fatty acids in children with inflammatory bowel disease - PubMed (original) (raw)
Comparative Study
Fecal short-chain fatty acids in children with inflammatory bowel disease
W R Treem et al. J Pediatr Gastroenterol Nutr. 1994 Feb.
Abstract
Nutrition of colonic epithelial cells (colonocytes) is maintained by luminal short-chain fatty acids (SCFAs), chiefly by n-butyrate. The importance of SCFAs for the maintenance of colonic epithelium has been demonstrated in animal models of colitis produced by rectal instillation of an inhibitor of SCFA oxidation and in patients with diversion colitis in whom a segment of colonic epithelium was deprived of contact with luminal SCFAs. We measured fecal SCFAs and lactate in children with ulcerative colitis (UC; n = 17) and with Crohn's disease with ileocolonic involvement (CD; n = 22) and age-matched controls (n = 12) by a vacuum-distillation, gas chromatographic method. Fecal SCFA concentrations were correlated with scores of clinical disease activity. Patients with UC and CD had a decrease in the fecal concentration of acetate (p < 0.05) and an increase in n-butyrate (p < 0.01) compared with controls. No significant changes in fecal lactate were seen. A comparison of inactive- or mild-UC patients with moderate or severe-UC patients yielded major differences in SCFA concentrations with n-butyrate increased in inactive and mild UC well above control values and total SCFA and acetate decreased in moderate and severe UC below control levels. Raised concentrations of fecal n-butyrate may reflect impaired utilization of this SCFA in the colon of patients with mild UC and Crohn's disease with colonic involvement. Whether this defect is primary or secondary to inhibitors in the colonic lumen, due to impaired transport of n-butyrate into the cell or defective metabolism within the cell, or specific to inflammatory bowel disease remains to be explored.
Similar articles
- Influence of intestinal inflammation (IBD) and small and large bowel length on fecal short-chain fatty acids and lactate.
Hove H, Mortensen PB. Hove H, et al. Dig Dis Sci. 1995 Jun;40(6):1372-80. doi: 10.1007/BF02065554. Dig Dis Sci. 1995. PMID: 7781463 - Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severity.
Tews HC, Elger T, Gunawan S, Fererberger T, Sommersberger S, Loibl J, Huss M, Liebisch G, Müller M, Kandulski A, Buechler C. Tews HC, et al. Lipids Health Dis. 2023 Oct 3;22(1):164. doi: 10.1186/s12944-023-01929-6. Lipids Health Dis. 2023. PMID: 37789460 Free PMC article. - Organic anions and the diarrhea of inflammatory bowel disease.
Vernia P, Gnaedinger A, Hauck W, Breuer RI. Vernia P, et al. Dig Dis Sci. 1988 Nov;33(11):1353-8. doi: 10.1007/BF01536987. Dig Dis Sci. 1988. PMID: 3180970 - Short-chain fatty acids in the human colon: relation to gastrointestinal health and disease.
Mortensen PB, Clausen MR. Mortensen PB, et al. Scand J Gastroenterol Suppl. 1996;216:132-48. doi: 10.3109/00365529609094568. Scand J Gastroenterol Suppl. 1996. PMID: 8726286 Review. - Colonic health: fermentation and short chain fatty acids.
Wong JM, de Souza R, Kendall CW, Emam A, Jenkins DJ. Wong JM, et al. J Clin Gastroenterol. 2006 Mar;40(3):235-43. doi: 10.1097/00004836-200603000-00015. J Clin Gastroenterol. 2006. PMID: 16633129 Review.
Cited by
- The Impact of Bioactive Molecules from Probiotics on Child Health: A Comprehensive Review.
Guamán LP, Carrera-Pacheco SE, Zúñiga-Miranda J, Teran E, Erazo C, Barba-Ostria C. Guamán LP, et al. Nutrients. 2024 Oct 30;16(21):3706. doi: 10.3390/nu16213706. Nutrients. 2024. PMID: 39519539 Free PMC article. Review. - No Impact of Enteral Nutrition on Fecal Short-Chain Fatty Acids in Children with Cerebral Palsy.
Mickiewicz-Góra D, Sznurkowska K, Drozd A, Borkowska A, Zagierski M, Troch J, Skonieczna-Żydecka K, Szlagatys-Sidorkiewicz A. Mickiewicz-Góra D, et al. Biomedicines. 2024 Apr 18;12(4):897. doi: 10.3390/biomedicines12040897. Biomedicines. 2024. PMID: 38672250 Free PMC article. - Human-derived bacterial strains mitigate colitis via modulating gut microbiota and repairing intestinal barrier function in mice.
Dai J, Jiang M, Wang X, Lang T, Wan L, Wang J. Dai J, et al. BMC Microbiol. 2024 Mar 23;24(1):96. doi: 10.1186/s12866-024-03216-5. BMC Microbiol. 2024. PMID: 38521930 Free PMC article. - Tezacaftor/Ivacaftor therapy has negligible effects on the cystic fibrosis gut microbiome.
Marsh R, Dos Santos C, Hanson L, Ng C, Major G, Smyth AR, Rivett D, van der Gast C. Marsh R, et al. Microbiol Spectr. 2023 Aug 21;11(5):e0117523. doi: 10.1128/spectrum.01175-23. Online ahead of print. Microbiol Spectr. 2023. PMID: 37607068 Free PMC article. - Gut Bacteria and Neurotransmitters.
Dicks LMT. Dicks LMT. Microorganisms. 2022 Sep 14;10(9):1838. doi: 10.3390/microorganisms10091838. Microorganisms. 2022. PMID: 36144440 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical